Researchers from two branches of the University of California as well as a former FDA commissioner assert that direct-to-consumer television ads for prescription drugs often fail to identify risk factors or alternative, drug-free treatments for the conditions the drugs are designed to treat.
In the study, the researchers report that they studied commercials recorded between June 30 and
According to the results published in the Annals of Family Medicine, only 26 percent of ads studied informed consumers about causes and risk factors for the conditions, and 25 percent reported the prevalence of the given condition. Not one of the ads talked about making lifestyle changes instead of taking the medicine, although 19 percent referenced lifestyle changes as something that could be made alongside regimens of the product. Eighteen percent of the advertisers suggested that lifestyle changes were not enough to control the conditions their products treated.
The study also noted that seven of the 38 ads captured in the study were “reminder” ads (promotions which tout the name of the drug but give no other information.) Reminder ads are the subject of a voluntary ban among major drug marketers.
The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other uncensored news on important consumer health topics, can be found at:
Study finds hardly any direct-to-consumer drug ads mention condition risks or alternative treatments
http://www.newstarget.com/021579.html
About NewsTarget
Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.